How much is the injectable cement market worth, and how is it expected to expand?
The injectable cement market size has grown strongly in recent years. It will grow from $1.45 $ billion in 2024 to $1.55 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing incidence of osteoporosis, increasing incidence of bone fractures, growing demand for joint replacement surgeries, regulatory approvals, and the and the market entry of new products.
The injectable cement market size is expected to see strong growth in the next few years. It will grow to $2 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to an aging population, increasing bone health concerns, the expansion of healthcare infrastructure, increasing adoption of outpatient care, and a and a rising incidence of sports-related injuries. Major trends in the forecast period include enhanced biocompatibility, antibiotic-loaded cement innovations, minimally invasive application techniques, patient-specific solutions, and smart cement with monitoring capabilities.
Get Your Free Sample of The Global Injectable Cement Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19528&type=smp
Which industry factors have accelerated the injectable cement market’s expansion?
The increasing number of sports-related injuries is expected to propel the growth of the injectable cement market going forward. Sports-related injuries are physical damages sustained during athletic activities, including strains, sprains, fractures, and concussions, often requiring medical attention and rehabilitation for recovery. The rise in sports-related injuries is likely attributed to increased participation in athletic activities, more intense training regimens, and advancements in sports equipment that push physical limits, leading to higher injury rates among athletes worldwide. Injectable cement is used to treat sports-related injuries to stabilize fractures, support bone healing, and enhance surgical outcomes by providing a reliable and minimally invasive solution for bone reinforcement. For instance, in 2023, according to the National Safety Council, a US-based nonprofit organization dedicated to health and safety, the number of sports and recreational injuries reported saw a 20% increase in 2021, followed by a 12% rise in 2022 and a 2% uptick in 2023. Therefore, increasing sports-related injuries will drive the growth of the injectable cement market.
What are the primary segments of the injectable cement market?
The injectable cementmarket covered in this report is segmented –
1) By Type: High Viscosity Cement, Low Viscosity Cement, Medium Viscosity Cement
2) By Application: Periprosthetic Fractures, Pelvic Fractures, Other Applications
3) By End User: Hospital, Clinics, Other End Users
Subsegments:
1) By High Viscosity Cement: Calcium Phosphate Cements, PMMA (Polymethyl Methacrylate) Cements
2) By Low Viscosity Cement: Acrylic-Based Injectable Cements, Bioactive Glass Cements
3) By Medium Viscosity Cement: Hybrid Injectable Cements, Composite Injectable Cements
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/injectable-cement-global-market-report
Which firms are leading the injectable cement market?
Major companies operating in the injectable cement market are Johnson & Johnson, 3M Company, Medtronic Plc., Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew, Arthrex Inc., Cook Medical LLC, Enovis Corporation, Globus Medical Inc., Wright Medical Group N.V, Medacta International, Orthofix Medical Inc., Alphatec Spine Inc. (ATEC Spine), Exactech Inc., Spine Wave Inc., Tecres SpA, Somatex Medical Technologies, Heraeus Medical GmbH, DJO Global Inc., TEKNIMED, G-21, Kyeron Medical Innovations, Graftys SA
Which market trends are set to define the future of the injectable cement market?
Major companies operating in the injectable cement market are focusing on technological advancements such as antibiotic-loaded bone cement to enhance infection control, improve patient outcomes, and support more effective and targeted treatment during orthopedic surgeries. Antibiotic-loaded bone cement is a type of bone cement that contains antibiotics mixed into the cement material to help prevent or treat infections at the surgical site, particularly in orthopedic procedures. For instance, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+C, its latest antibiotic-loaded bone cement. It is the first product from the company to be certified under the MDR. COPAL G+C combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly associated with prosthetic joint infections.
Which geographic trends are shaping the injectable cement market, and which region has the highest market share?
North America was the largest region in the injectable cement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Injectable Cement Market Report 2025 Offer?
The injectable cement market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Injectable cement is a type of bone cement used in various orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is designed to be injected into a targeted body area, often under imaging guidance, allowing for precise placement and minimal invasiveness. Injectable cements are valued for providing immediate stabilization, facilitating minimally invasive procedures, and improving patient outcomes in orthopedic care.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19528
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
